Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis

International Journal of Clinical Practice
G YücesoyK Babaoğlu

Abstract

This study was conducted to find out the group B streptococcus colonisation of pregnant women in Kocaeli, Turkey. A culture plus individualised high-risk-based antibiotic prophylaxis was compared with high-risk-based approach alone. The screening of women was performed via vaginal and anal cultures for group B streptococcus (GBS). The maternal GBS colonisation rate was found to be 6.5%. All colonised women or preterm labours with unavailable culture results until delivery received prophylactic antibiotics. Neonatal colonisation rate and early-onset neonatal sepsis due to GBS was 1/200. The unscreened 900 women received prophylactic antibiotics due to a risk factor-based approach. The neonatal colonisation rate was 17/900 (p = 0.1), and the rate of early-onset neonatal sepsis was 3/900 (p = 0.6). A culture plus individualised high-risk-based antibiotic prophylaxis provided an insignificant change in neonatal colonisation and early-onset neonatal sepsis with GBS when compared with high-risk-based approach alone.

References

Jun 26, 1986·The New England Journal of Medicine·K M Boyer, S P Gotoff
Jun 1, 1996·American Journal of Obstetrics and Gynecology·R A McLarenT L Gross
Dec 17, 1998·American Journal of Obstetrics and Gynecology·S H FactorA Schuchat
Aug 24, 1999·American Journal of Obstetrics and Gynecology·W J MoralesD V Lim
Oct 16, 1999·American Journal of Obstetrics and Gynecology·B M MercerB M Sibai
Jan 6, 2000·The New England Journal of Medicine·S J SchragA Schuchat
May 18, 2000·The New England Journal of Medicine·R L GoldenbergW W Andrews
Jun 28, 2000·American Journal of Obstetrics and Gynecology·D P ReisnerD A Luthy
Mar 3, 2001·American Journal of Obstetrics and Gynecology·D R FeikinA Schuchat
Oct 20, 2001·American Journal of Obstetrics and Gynecology·J R JohnsonC S Shellhaas
Apr 23, 2002·American Journal of Obstetrics and Gynecology·George D WendelJane D Siegel
Jul 26, 2002·The New England Journal of Medicine·Barbara J StollW Kenneth Poole

❮ Previous
Next ❯

Citations

Mar 30, 2010·Archives of Gynecology and Obstetrics·Talita T RocchettiMárcia G da Silva
Nov 24, 2011·Epidemiology and Health·Eun Ju KimMoran Ki
Mar 4, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P J ChengY K Soong
Aug 3, 2010·São Paulo Medical Journal = Revista Paulista De Medicina·Camila MarconiMárcia Guimarães da Silva
Sep 22, 2017·Human Vaccines & Immunotherapeutics·Min Joo ChoiJoon Young Song
Jan 19, 2008·American Journal of Obstetrics and Gynecology·John W Larsen, John L Sever

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Australian & New Zealand Journal of Obstetrics & Gynaecology
K W TanS H Lim
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D F ZaleznikC J Baker
© 2021 Meta ULC. All rights reserved